Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07380009
NA

Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Receiving Antibiotic Therapy.

Sponsor: University of Thessaly

View on ClinicalTrials.gov

Summary

This open-label interventional study aims to evaluate the acceptability and adherence of adult participants to the multistrain probiotic Vivomixx® 460 Neo 9 when administered concurrently with antibiotic therapy. Participants are randomized to receive one of two dosing regimens: a low daily dose or a high daily dose. The study will assess the effects of these regimens on the prevention of antibiotic-associated diarrhea (AAD), gastrointestinal symptoms, and patient adherence and acceptability. The results are intended to provide evidence to optimize the clinical use of probiotics alongside antibiotics.

Official title: Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Receiving Antibiotic Therapy: a Randomized, Open-label Clinical Trial.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-12-12

Completion Date

2026-05-30

Last Updated

2026-02-02

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

One sachet of the probiotic daily

Twenty participants will receive one sachet of the probiotic daily.

DIETARY_SUPPLEMENT

Two sachets of the probiotic daily

Twenty participants will receive two sachets of the probiotic daily.

Locations (1)

School of Physical Education, Sport Science and Dietetics

Trikala, Greece